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Recent studies have suggested that human pluripo-
tent stem cells (hPSCs) depend primarily on glycol-
ysis and only increase oxidative metabolism during
differentiation. Here, we demonstrate that both
glycolytic and oxidative metabolism can support
hPSC growth and that the metabolic phenotype of
hPSCs is largely driven by nutrient availability. We
comprehensively characterized hPSC metabolism
by using 13C/2H stable isotope tracing and flux anal-
ysis to define the metabolic pathways supporting
hPSC bioenergetics and biosynthesis. Although
glycolytic flux consistently supported hPSC growth,
chemically defined media strongly influenced the
state of mitochondrial respiration and fatty acid
metabolism. Lipid deficiency dramatically reprog-
ramed pathways associated with fatty acid biosyn-
thesis and NADPH regeneration, altering the mito-
chondrial function of cells and driving flux through
the oxidative pentose phosphate pathway. Lipid
supplementation mitigates this metabolic reprog-
ramming and increases oxidative metabolism. These
results demonstrate that self-renewing hPSCs can
present distinct metabolic states and highlight the
importance of medium nutrients on mitochondrial
function and development.INTRODUCTION
Given their virtually unlimited expansion potential and differenti-
ation capacity, human pluripotent stem cells (hPSCs) offer
unique opportunities in the study of human development, bio-
chemical screening in specific lineages, and regenerative medi-
cine. Successful establishment of culture conditions able to
maintain human embryonic stem cells (hESCs) and induced
pluripotent stem cells (iPSCs) in the undifferentiated state repre-1536 Cell Reports 16, 1536–1547, August 9, 2016 ª 2016 The Author
This is an open access article under the CC BY license (http://creativesented critical steps in advancing these technologies to practice
(Thomson et al., 1998; Takahashi and Yamanaka, 2006). How-
ever, the large quantity of cells needed for screening and tissue
engineering applications poses a challenge that must still be
addressed (Desai et al., 2015). Initial protocols for hPSC self-
renewal mimicked the in vivo microenvironment by using feeder
cell co-culture or medium conditioned by feeder cells to support
hPSC expansion (Villa-Diaz et al., 2013; Desai et al., 2015). How-
ever, current good manufacturing practices (cGMPs) and Food
and Drug Administration (FDA) guidelines that encourage the
use of xenobiotic-free systems in clinical applications of hPSCs
have driven efforts to develop chemically defined and/or xenobi-
otic-free media and substrates for hPSC maintenance (Kirouac
and Zandstra, 2008; Hyun et al., 2008; Carpenter and Couture,
2010). In recent years, such chemically defined formulations
have supplanted undefined conditions as the gold standard for
expansion of hPSCs (Ludwig et al., 2006; Chen et al., 2011).
However, the metrics for evaluation of such media have often
been limited to proliferation, pluripotency, and gene expression
analyses, an established challenge that must still be overcome
(Ungrin et al., 2007). Indeed, recent studies now suggest that cul-
ture and/or passaging conditions can influence the genetic sta-
bility, metabolism, and differentiation potential of hPSCs (Lau-
rent et al., 2011; Badur et al., 2015; Lee et al., 2015). The
specific metabolic features of hPSCs adapted to chemically
defined media must be elucidated in greater detail to develop
improved hPSC models and related biomedical products.
Several recent studies have identified critical metabolic path-
ways necessary for cellular reprogramming and/or maintaining
pluripotency, evoking a broader interest in applying hPSCs to
study nutrition, development, and metabolic disease (Ben-Zvi
and Melton, 2015). Glycolytic flux is commonly high in hPSC cul-
tures, and inhibition of glucose metabolism potently limits re-
programming efficiency (Folmes et al., 2011; Panopoulos et al.,
2012; Zhu et al., 2010). Metabolites that serve as substrates for
epigenetic markers such as acetylation and methylation have
also emerged as critical regulators of pluripotency (Moussaieff
et al., 2015; Shiraki et al., 2014; Wang et al., 2009; Shyh-Chang
et al., 2013). Broader characterization of the hPSC metabolome
has also identified key differences in mitochondrial function and(s).
commons.org/licenses/by/4.0/).
lipid metabolism between hPSCs, mouse (m)ESCs, and their de-
rivatives (Panopoulos et al., 2012, Yanes et al., 2010). In addition,
compounds that promote mitochondrial metabolism can nega-
tively influence cellular reprogramming (Folmes et al., 2011; Pan-
opoulos et al., 2012; Zhu et al., 2010), leading to the generalized
concept that oxidative mitochondrial metabolism is ‘‘antago-
nistic’’ to the pluripotent state (Zhang et al., 2012). However,
some evidence suggests that mitochondria are active in hESCs
(Zhang et al., 2011). Similar to recent developments in tumor
biology (Viale et al., 2014), critical roles for mitochondria in
hPSC growth are likely to emerge.
Here we conducted a comprehensive analysis of metabolic
fluxes in hPSCs. Using an array of 13C and 2H tracers, we inves-
tigated the metabolic pathways that support hPSC biosynthesis
and growth. Surprisingly, we observed that distinct metabolic
states marked by high mitochondrial flux and governed by
nutrient availability can maintain hESC self-renewal, challenging
the notion that mitochondrial function is dispensable for stem
cell function. Chemically defined medium drives hPSCs to regu-
late mitochondrial pathways to support lipid biosynthesis at
the expense of oxidative metabolism. Media containing lipid
supplements maintain pluripotency while augmenting respira-
tion and mitochondrial metabolism. Taken together, these
results demonstrate that nutrient availability and the microenvi-
ronment (in particular, medium choice) profoundly affect hPSC
metabolism.
RESULTS
Medium Choice Influences hESC Metabolic States
To define the critical metabolic features of self-renewing hPSCs,
we quantified intracellular metabolite abundances, nutrient up-
take, and byproduct secretion in undifferentiated HUES 9 and
H9 cells. Because researchers employ a variety of validated me-
dium formulations to maintain hPSCs (Thomson et al., 1998;
Chen et al., 2011), we compared the metabolic state of hESCs
in murine embryonic fibroblast conditioned medium (MEF-CM)
or more chemically defined, commercially available media
such as Essential 8 (E8). We employed this strategy to deconvo-
lute medium-specific metabolic pathway functions from cellular
pluripotency. hESCs were maintained in each medium formula-
tion for at least three passages. Consistent with previous obser-
vations established during the establishment of these media
(Thomson et al., 1998; Chen et al., 2011), hESCs under all condi-
tions exhibited robust expression of OCT4 (Figures 1A and 1B).
Notably, we observed a more compact, flattened colony
morphology of hESCs cultured in chemically defined media
and a larger, non-nuclear area of hESCs cultured in MEF-CM,
suggesting a difference in the quantity of cytosolic biomass be-
tween both pluripotent cells (Figure 1B). We also noted striking
differences in the dry cell weight of hESCs adapted to chemically
defined media, which was nearly 50% lower than that observed
in MEF-CM cells (Figure 1C; Figure S2A).
To gain more insights into pathway-specific differences
across these conditions, we next quantified the abundance of
intracellular organic and amino acids in each hESC population.
In chemically defined media, we observed consistent increases
in the per-cell abundance of pyruvate (Pyr), lactate (Lac), andmost tricarboxylic acid (TCA) intermediates (Figure 1D; Fig-
ure S2B) despite the smaller cell size (Figure 1C; Figure S2A).
Amajor exception to these trendswas citrate, whichwas present
at significantly lower levels in E8 medium. Consistent with these
differences, glycolytic flux in E8was significantly higher on a per-
protein basis (Figure 1E). Additionally, glutamine consumption
was markedly elevated in chemically defined media, and net
glutamine anaplerosis (i.e., glutamine uptake minus glutamate
secretion or entry of glutamine carbon into the TCA cycle)
was increased 4-fold (Figure 1F). These results suggest that
different hPSC media drive metabolic reprogramming of hESCs
independent of pluripotency.
Medium-Dependent Reprogramming of Amino Acid and
Redox Metabolism
The inherent redundancy of metabolic networks allows for mul-
tiple pathways and substrates to support cellular bioenergetics
and biosynthesis. Indeed, the differences observed in the above
metabolic characterizations suggest that intermediary metabolic
fluxes are altered in hESCs cultured in MEF-CM versus chemi-
cally defined media. To investigate these changes in greater
detail, we cultured HUES 9 and H9 cells in the presence of
[13C]glucose, [2H]glucose, or [13C]glutamine tracers and quanti-
fied isotopic labeling to probe central carbon metabolism (see
Figure S1 for atom transitionmaps). With the exception of serine,
the contribution of glucose carbon to glycolytic and TCA inter-
mediates was not dramatically affected by medium choice (Fig-
ure 2A; Figure S3). On the other hand, flux of glucose through the
oxidative pentose phosphate pathway (PPP) was increased
3-fold in E8 medium compared with MEF-CM (Figure 2B). To
better quantify how oxidative PPP flux contributes to nicotin-
amide adenine dinucleotide phosphate (NADPH) regeneration,
we quantified label transfer from [3-2H]glucose to palmitate
and performed isotopomer spectral analysis (ISA) (Lewis et al.,
2014). In E8 medium, the oxidative PPP accounted for 52% ±
2% and 67% ± 1% of cytosolic NADPH pool H9 and HUES 9
hESCs, respectively (Figure 2C). Because the oxidative PPP is
often upregulated in highly proliferative cells, such as tumors,
to support nucleotide and fatty acid synthesis (Patra and Hay,
2014), we also performed the same tests in multiple established
stable cancer cell lines. We found the contribution of PPP flux to
NADPH production to be significantly higher in hESCs than that
observed in all cancer cell lines tested (Figure 2C; Supplemental
Experimental Procedures), even when growing cancer cells in
E8 medium rather than in DMEM + fetal bovine serum (FBS)
(Figure S2C).
Glutamine is another important substrate that fuels mitochon-
drial metabolism in proliferating cells (DeBerardinis et al., 2007;
Ahn and Metallo, 2015). When culturing HUES 9 or H9 hESCs
in the presence of [U-13C5]glutamine, we observed significant
changes in the overall contribution and labeling patterns of
various TCA intermediates and amino acids in MEF-CM versus
E8 medium (Figure 2D; Figures S2D and S4). These data indi-
cated that glutaminolysis was highly active in hESCs cultured
on all media to support TCA cycle anaplerosis but significantly
higher in defined media (Figure 2D; Figures S2D and S4).
Notably, cells became cytostatic upon glutamine withdrawal
(data not shown) in contrast to murine ESCs, which canCell Reports 16, 1536–1547, August 9, 2016 1537
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Figure 1. Distinct Metabolic States Exist in hESCs Adapted to MEF-CM versus Chemically Defined Media
HUES 9 and H9 hESCs were cultured in either MEF-CM or chemically defined media for at least three passages.
(A) Percentage of OCT4+ hESCs. OCT4 is shown in green and the immunoglobulin G (IgG) control in gray.
(B) Representative HUES 9 hESC colonies. The insets show increased distance between nuclei in MEF-CM cells. Scale bar, 100 mm. BF, bright field.
(C) Dry cell weight per million HUES 9 hESCs.
(D) Relative intracellular metabolite abundance of HUES 9 hESCs normalized by cell number and MEF-CM sample. Metabolite abbreviations are defined in the
Supplemental Experimental Procedures.
(E) Glucose uptake and lactate secretion fluxes of HUES 9 hESCs.
(F) Glutamine uptake and glutamate secretion fluxes of HUES 9 hESCs.
(A and C–F) All results are shown as mean ± SEM.
(C–F) p values were calculated using Student’s two-tailed t test relative to MEF-CM condition. *p = between 0.01 and 0.05, **p = between 0.001 and 0.01,
***p < 0.001.proliferate in the absence of available glutamine (Carey et al.,
2015). Increased M+3 labeling of citrate, malate (Mal), fumarate
(Fum), and aspartate suggested that reductive carboxylation and
ATP-citrate lyase activity (in the case of citrate) were both
elevated in cells cultured in E8 (Figure S4). We confirmed that
glutamine-mediated reductive carboxylation flux was increased
in chemically defined culture media by tracing the contribution
of [1-13C]glutamine to various intermediates (Figure 2E). This
NADPH-dependent pathway can fuel lipid biosynthesis via cit-
rate and is particularly active under conditions of oxidative stress
or hypoxia-inducible factor (HIF) stabilization (Metallo et al.,
2011; Mullen et al., 2011; Wise et al., 2011; Fendt et al., 2013).1538 Cell Reports 16, 1536–1547, August 9, 2016In addition, we observed elevated levels of 2-hydroxyglutarate
(2HG) in cells grown in chemically defined medium (Figure 2F).
We confirmed this metabolite as the (R)-2HG enantiomer via chi-
ral chromatography (Figure S2E; Supplemental Experimental
Procedures), suggesting that this 2HG was produced by IDH1.
However, the levels present in all conditions were significantly
lower than that required for modulation of alpha-ketoglutarate
(aKG)-dependent dioxygenase activity (Xu et al., 2011; Grassian
et al., 2014). These results suggest that the TCA cycle, the cen-
tral hub of mitochondrial oxidative energy generation, resides in
distinct states within hESCs depending on the nutritional envi-
ronment of cells.
A B
C D
E F
en
ric
hm
en
t (
%
)
en
ric
hm
en
t (
%
)
(p
m
ol
/n
g 
dr
y 
ce
ll 
w
ei
gh
t-h
r)
Figure 2. Medium Choice Influences Glucose, Glutamine, and NADPH Metabolism
(A) MPE from [1,2-13C2]glucose in HUES 9 hESCs throughout intermediary metabolism.
(B) Absolute flux through the oxidative PPP in HUES 9 hESCs.
(C) Contribution of oxidative PPP to lipogenic NADPH as determined by ISA in hESCs and cancer cells. Results are shown as mean and 95% CI. *, significance
indicated by non-overlapping 95% confidence intervals.
(D) MPE from [U-13C5]glutamine in HUES 9 hESCs throughout intermediary metabolism.
(E) MPE of TCA intermediates from [1-13C]glutamine (normalized by MPE of aKG) in HUES 9 hESCs.
(F) Relative abundance of 2HG in HUES 9 hESCs normalized by cell number and MEF-CM sample.
(A, B, and D–F) All results shown as mean ± SEM. p values were calculated using Student’s two-tailed t test relative to MEF-CM condition. *p = between 0.01 and
0.05, **p = between 0.001 and 0.01, ***p < 0.001.Chemically Defined Medium Dramatically Increases
Lipogenesis
The increased reductive carboxylation and 2HG production
noted above provide some mechanistic insight into why oxida-
tive PPP flux is elevated in defined media. However, in addition
to the changes in intermediary metabolism, we observed signif-icant decreases in per-cell fatty acid abundances in HUES 9 and
H9 hESCs maintained in more defined media, such as E8 and
mTeSR1, versusMEF-CM (Figure 3A), consistent with our obser-
vation of decreased dry cell weight of hESCs in the latter (Fig-
ure 1C; Figure S2A). We next employed [U-13C6]glucose and
ISA to quantify de novo lipogenesis in hESCs cultured in theCell Reports 16, 1536–1547, August 9, 2016 1539
samemedium panel. This analysis highlighted drastic changes in
the extent to which hESCs synthesized fatty acids and choles-
terol in different media. Although hESCs exhibited minimal lipo-
genesis in MEF-CM over 24 hr, HUES 9 and H9 cells synthesized
50%–80% of their palmitate and cholesterol in E8 or mTESR1
over the same time period (Figure 3B). Notably, the contribution
of glucose to lipogenic acetyl coenzyme A (AcCoA) pools did not
change appreciably in different media, consistent with glucose
labeling of citrate under each condition (Figures S5A and S5B).
These results demonstrate that hESCs exhibit marked differ-
ences in lipid biosynthesis when cultured in different media.
Both MEF-CM and mTeSR1 formulations contain exogenous
lipid supplements (AlbuMAX and chemically defined lipid con-
centrate, respectively) that may support hPSC growth, although
our results indicate that the levels present in mTeSR1 are insuf-
ficient. To further dissect how exogenous lipids are used and
metabolized in chemically defined media, we supplemented E8
with albumin-bound [U-13C16]palmitate (U-Palm E8) as the sole
source of fatty acids (Figure 3C). After 24 hr, we quantified fatty
acid and TCA intermediate labeling in hESCs. No appreciable
isotope enrichment was detected in citrate or other TCA metab-
olites (data not shown), indicating that b-oxidation is not em-
ployed by self-renewing hESCs to generate AcCoA. However,
M+16 labeling of C16:0 palmitate and C18:0 stearate was
observed, suggesting that exogenous fatty acids are readily
utilized and elongated in hESCs cultured in chemically defined
medium (Figures 3D and 3E).
The metabolic changes outlined above center around path-
ways associated with de novo lipogenesis, NADPH regenera-
tion, and glutaminolysis. To better understand how cells coordi-
nate the observed changes in metabolic flux, we quantified the
expression of various enzymes catalyzing these reactions.
Consistent with this metabolic shift toward lipid biosynthesis
and NADPH production, we observed significant increases in
the expression of ACACA, ACLY, FAS, SCD, G6PD, and GLS2
(Figure 3F). Importantly, all of these genes (with the exception
of GLS2) are targets of the sterol response element binding pro-
teins (SREBPs), providing evidence that cells sense lipid defi-
ciency and respond transcriptionally through the established
SREBP pathway (Porstmann et al., 2008). Recent studies have
implicated GLS2 specifically in both antioxidant function and
as being necessary for differentiation (Hu et al., 2010; Suzuki
et al., 2010; Velletri et al., 2013). These results indicate that nutri-
tional availability influences both metabolic fluxes and gene
expression in hESCs.
Lipid Supplementation Mitigates hESC Metabolic
Reprogramming
Our results demonstrate that hESCs in different medium compo-
sitions can self-renew in distinct metabolic states, exemplified
by drastic changes in NADPH, lipid, and amino acid metabolism.
More specifically, these differences suggest that insufficient lipid
availability in media, including mTeSR1 and E8, drive medium-
induced metabolic reprogramming, which influences metabolic
rates (as indicated above) and, potentially, cellular epigenetics
(Moussaieff et al., 2015). To determine whether lipids produced
by irradiated MEFs drove these changes, we conditioned media
in the presence of [U-13C6]glucose. Although glucosewas readily1540 Cell Reports 16, 1536–1547, August 9, 2016metabolized by MEFs to citrate (Figure S5C), no appreciable
accumulation of labeled lipids was observed after conditioning
(Figure S5D). This finding suggests that lipids present in basal
medium may support hESC growth.
The predominant lipid source in basal hESC medium is Albu-
MAX within the knockout serum replacer (KSR) supplement.
This reagent contains albumin, fatty acids, cholesterol, and other
lipids, and, in some background media, it can improve hESC
growth (Garcia-Gonzalo and Izpisu´a Belmonte, 2008). To deter-
mine whether lipid supplementation in chemically defined media
can mitigate the metabolic reprogramming described above, we
added AlbuMAX to E8 at a final concentration of 1.6% (E8+Albu-
MAX), equivalent to that present inMEF-CM. Short-term addition
of AlbuMAX did not affect OCT4 expression, although more
extensive studies are required to demonstrate its ability to sup-
port long-term hPSC expansion in specific medium back-
grounds (Figure S5E). Notably, AlbuMAX supplementation to
E8 rescued some of the changes in intracellular metabolite levels
that we observed in defined medium. Specifically, glycolytic
(Pyr, Lac) and various TCA intermediates (succinate [Suc],
Fum, Mal) decreased significantly, whereas levels of the lipo-
genic metabolite citrate and aKG were increased (Figure 4A).
Only a marginal effect on glucose uptake and Lac secretion
was observed (Figure S5F), presumably because of the impor-
tance of glycolysis for pluripotency (Folmes et al., 2011; Pano-
poulos et al., 2012; Zhu et al., 2010) and the need for continued
non-essential amino acids (NEAA) biosynthesis (e.g., serine,
glycine), which were not supplemented further. However, net
glutamine anaplerosis decreased in HUES 9 cells after addition
of AlbuMAX, as noted by the increased glutamate secretion
observed (Figure S5G).
Additionally, we quantified relevant flux changes in cells
cultured in lipid-supplemented E8 versus basal E8 medium.
Oxidative PPP flux was significantly decreased in HUES 9 and
H9 cells under these conditions (Figure 4B). Furthermore, the
contribution of PPP flux to lipogenic NADPHwas also decreased
in these cells (Figure 4C). Less robust changes may have
occurred in PPP flux in IMR90-iPSC cultures because they
were maintained for an extended number of passages in lipid-
deficient media prior to supplementation (Figure 4B). On the
other hand, fatty acid (palmitate) and cholesterol synthesis
were significantly decreased in all hPSCs upon AlbuMAX addi-
tion (Figures 4D and 4E).
Lipid supplementation also influenced the general phenotype
of hPSCs. Lipid supplementation significantly decreased the tran-
scription of most enzymes involved in de novo lipogenesis that
were previously observed to be upregulated in chemically defined
media, with consistent results obtained in HUES 9 and H9 hESCs
as well as an IMR90-derived iPSC line (Figures 5A–5C). Addition-
ally, per-cell dry weight increased significantly in E8+AlbuMAX
HUES 9, H9, and IMR90-iPSC cultures (Figure 5D). In our hands,
HUES 9 cell growth was not affected by growth in E8+AlbuMAX
when additional BSA was included in the formulation. However,
some growth suppression was observed in H9 and IMR90-iPS
hPSCs (data not shown), indicating that additional optimization
of lipid supplement background medium combinations may be
needed. To more functionally characterize mitochondria under
these conditions, we conducted a respirometry analysis. Basal,
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Figure 3. hESCs Adapted to Chemically Defined Media Upregulate Lipid Biosynthesis
(A) Relative fatty acid abundance in cells adapted to MEF-CM, E8, and mTeSR1 normalized by MEF-CM sample. Left and right: HUES 9 and H9 hESCs,
respectively.
(B) Percentage of newly synthesized palmitate and cholesterol after 24 hr. Left and right: HUES 9 and H9 hESCs, respectively. Results are shown as mean and
95% CI. *, significance indicated by non-overlapping 95% confidence intervals.
(C) Schematic of [U-13C16]palmitate metabolism. Open circles depict
12C and filled circles depict 13C atoms. Metabolite abbreviations are defined in the
Supplemental Experimental Procedures.
(legend continued on next page)
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Figure 4. Lipid Supplementation Mitigates Medium-Induced Metabolic Flux Alterations
hPSCs were cultured in either E8 or E8 with 1.6% (w/v) AlbuMAX for at least three passages.
(A) Relative metabolite abundance of HUES 9 hESCs normalized by cell number and E8 sample.
(B) Absolute oxidative PPP fluxes in hPSCs.
(C) Contribution of oxidative PPP to lipogenic NADPH as determined by ISA in HUES 9 and H9 cells.
(D) Percentage of newly synthesized palmitate after 24 hr.
(E) Percentage of newly synthesized cholesterol after 24 hr.
(A and B) All results are shown asmean ±SEM. p valueswere calculated using Student’s two-tailed t test relative to E8. *p = between 0.01 and 0.05, **p = between
0.001 and 0.01, ***p < 0.001.
(C and E) Results are shown as mean and 95% CI. *Significance indicated by non-overlapping 95% confidence intervals.ATP-linked oxygen consumption was significantly lower in HUES
9 cells cultured in E8 comparedwith thosemaintained inMEF-CM
(Figure 5E; Figure S6A). Consistent with the rescue experiments
above, supplementation of AlbuMAX to E8 significantly increased
the respiration of HUES 9, H9, and IMR90 iPSCs (Figure 5F; Fig-
ures S6A–S6C). Taken together, these data indicate that lipid defi-
ciency of chemically defined media induced a profound reliance
on biosynthetic fluxes because of the need for structural lipids
in proliferating hESCs. In turn, this metabolic reprogramming in-
fluences the respiratory state, gene expression profile, and mito-
chondrial function of hPSCs. These data strongly contrast the
concept of mitochondrial inactivity as a key requirement for plu-(D) Percentage of M+16 fatty acids in HUES 9 hESCs cultured in E8+ BSA-boun
(E) Mass isotopomer distribution of palmitate and stearate in HUES 9 hESCs cul
(F) Expression of genes encoding various metabolic enzymes in HUES 9 hESCs
(A and D–F) All results are shown as mean ± SEM.
(A and F) p values were calculated using Student’s two-tailed t test relative to M
***p < 0.001.
1542 Cell Reports 16, 1536–1547, August 9, 2016ripotency-associated metabolic reprogramming and illustrate
the confounding effects of nutrient availability in hPSC metabolic
studies.
DISCUSSION
The prevailing view of hPSC metabolism is highly reminiscent of
tumor cell metabolism in that aerobic glycolysis is thought to be
favored over oxidative mitochondrial metabolism (Vander Hei-
den et al., 2010; Zhang et al., 2012; Vacanti and Metallo, 2013;
Prigione et al., 2010). These findings are supported by metabolic
studies predominantly conducted in chemically defined mediad [U-13C16]palmitate and 1 mM carnitine.
tured in E8 with BSA-bound [U-13C16]palmitate and 1 mM carnitine.
adapted to E8 relative to cells in MEF-CM.
EF-CM condition. *p = between 0.01 and 0.05, **p = between 0.001 and 0.01,
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Figure 5. Lipid Supplementation Mitigates Medium-Induced Metabolic Enzyme Expression and Mitochondrial State Alterations
(A–C) Expression of genes encoding various metabolic enzymes in hPSCs adapted to E8+AlbuMAX relative to cells in E8. (A) HUES 9. (B) H9. (C) IMR90-iPS.
(D) Dry cell weight per million hPSCs.
(E) Relative ATP-linked OCR of HUES 9 hESCs in MEF-CM and E8, normalized by MEF-CM sample.
(F) Relative ATP-linked OCR of hPSCs cells in E8 and E8+AlbuMAX, normalized by E8 sample.
All results are shown as mean ± SEM. p values were calculated using Student’s two-tailed t test relative to E8 condition. *p = between 0.01 and 0.05,
**p = between 0.001 and 0.01, ***p < 0.001.and/or the effect of metabolic inhibitors on reprogramming effi-
ciency in fast-growing cultures (Folmes et al., 2011; Panopoulos
et al., 2012; Zhu et al., 2010). In other studies using MEF-CM as
the primary maintenance condition, metabolic analysis was
limited to respirometry, with little focus on pathways involved
in biosynthesis (Zhou et al., 2012; Folmes et al., 2012). Our re-
sults demonstrate that distinct metabolic states can support
self-renewing hESCs when cultured under different nutrient con-
ditions (Figure 6). In cancer biology, recent studies have shed
light on the importance of mitochondria for tumor cell growth
and survival as well as the potential efficacy of mitochondrial in-
hibitors as therapies (Viale et al., 2014; Wheaton et al., 2014).
Although glycolysis similarly supports hESC growth under all
conditions, our data suggest that oxidative mitochondrial meta-
bolism is highly active in hESCs when lipids are present and
sustained by glutamine anaplerosis. Amino acid availability
also presumably affected serine, glycine, asparagine, and pro-
line metabolism in our system because each of these metabo-
lites was differentially labeled in MEF-CM and chemically
defined media.
Although numerous studies have demonstrated that pluripo-
tency and proliferation are robustly maintained in both MEF-CM and chemically defined medium alternatives (Ludwig et al.,
2006; Chen et al., 2011), our metabolic flux analysis (MFA) exper-
iments indicate that hPSCs are capable of adapting metabolism
to different nutrient conditionswhilemaintaining their self-renewal
capacity. In particular, medium lipid deficiency influences the
metabolic state of hESCs so that they strongly upregulate path-
ways involved in lipid biosynthesis and NADPH regeneration
(i.e., the oxidative PPP). This metabolic state may render cells
more susceptible to oxidative stresses. For example, highNADPH
consumption fueling lipid synthesis in cancer cells can increase
their susceptibility to metabolic or environmental stresses (Jeon
et al., 2012). Additionally, glucose-6-phosphate dehydrogenase
(G6PD) deficiency is a relatively common inborn error of meta-
bolism (IEM) in the human population (Stanton, 2012). As such,
mutations in G6PD may affect the efficiency of iPSC reprogram-
ming in some populations or potentially affect the genetic stability
and redox sensitivity of hPSCs cultured in chemically defined or,
more specifically, lipid-free media.
hPSC applications in disease modeling, drug screening, and
regenerative medicine all require the robust production of differ-
entiated lineages that correctly recapitulate the metabolic func-
tions of somatic tissue. Organogenesis is a complex, multistepCell Reports 16, 1536–1547, August 9, 2016 1543
Figure 6. Nutrient Availability Reprograms
Intermediary Metabolism in hPSCs
Culture of hPSCs in chemically defined media
(CDM) reprograms glucose, glutamine, lipid, and
NADPH metabolism. Lipid deficiency induces the
upregulation of oxidative PPP flux for NADPH
synthesis, de novo lipogenesis, and reductive
carboxylation while diverting carbon from the TCA
cycle and decreasing mitochondrial respiration
(ATP-linked activity of the mitochondrial electron
transport chain [ETC]). Amino acid deficiencies
influence glutaminolysis and synthesis of proline,
asparagine, and serine, which are upregulated
in hPSCs cultured in defined media. Metabolic
genes are shown in italics. Metabolite abbrevia-
tions are defined in the Supplemental Experi-
mental Procedures.process that requires significant energy, biomass, and signaling
cues; metabolism plays an essential role in all aspects of these
processes. Subjecting hPSCs to selective pressures in vitro,
such as medium lipid deficiency, may limit their ability to accu-
rately represent normal tissue function in subsequent applica-
tions without giving rise to ‘‘harmful’’ genetic alterations (Peter-
son and Loring, 2014). Furthermore, culture and passaging
conditions as well as time can influence the genetic and epige-
netic stability of hPSCs (Laurent et al., 2011; Garitaonandia
et al., 2015) or metabolic rates after subculture (Badur et al.,
2015). Our MFA results provide potential mechanisms that may
be exploited to alleviate some of the stresses associated with
long-term in vitro expansion. Specifically, addition of particular
lipids may enhance or better control hPSC expansion and differ-
entiation. As such, pluripotency analysis (e.g., teratoma forma-
tion) and proliferation alone may not be suitable metrics for the
evaluation of hPSC culture media, and intracellular metabolic
fluxes should also be considered. MFA is an ideal and underutil-
ized tool for such applications.
Numerous studies have recently implicatedmetabolites or cul-
ture conditions in regulating the cellular epigenetics and differen-
tiation propensity of pluripotent stem cells. Metabolites that
affect methylation (Carey et al., 2015; Wang et al., 2009; Shiraki
et al., 2014) and acetylation (Moussaieff et al., 2015) can influ-
ence differentiation but likely play more critical roles in cellular
bioenergetics and biosynthesis. Indeed, it is unclear how global
changes in the abundance of s-adenosyl methionine (SAM) or
AcCoA can affect the specific epigenetic state of pluripotency
genes. Other studies have recently identified key differences in1544 Cell Reports 16, 1536–1547, August 9, 2016the predisposition of cells to differentiate
to neural or hematopoietic lineages
when culturing or priming cells in MEF-
CM versus more nutrient-limited media,
such as E8 or mTeSR1 (Lee et al., 2015;
Lippmann et al., 2014). Finally, the mito-
chondrial state and lipid profile of cells
changes significantly during the course
of mESC and hESC differentiation (Yanes
et al., 2010). Our results therefore demon-
strate the importance of considering thebroader nutritional environment and intracellular metabolic state
of hPSCs when characterizing metabolic regulation in stem cells
and designing hPSC media.
EXPERIMENTAL PROCEDURES
hPSC Culture
The human embryonic stem cell lines HUES 9 and WA09 (H9) and the human
induced pluripotent stem cell line iPS(IMR90)-c4 were maintained on plates
coated with Matrigel (Corning Life Sciences) at 8.8 mg/cm2 and adapted to
MEF-CM, Essential 8 medium (Life Technologies), and mTeSR1 medium
(STEMCELL Technologies) for at least three passages before experiments.
All hPSCs were passaged every 5 days by exposure to Accutase (Innovative
Cell Technology) for 5–10 min at 37C. For metabolic flux experiments, 13
minimum essential medium (MEM) non-essential amino acid solution was
added to E8 medium to control for amino acid levels. Tracer MEF-CM con-
sisted of low-glucose or glutamine-free MEF-CM supplemented with either
[13C] glucose or [13C] glutamine tracers, respectively. Tracer chemically
defined medium consisted of glucose or glutamine-free E8 medium supple-
mented with [13C] glutamine, [13C] glucose or [2H] glucose, or E8 medium sup-
plemented with [13C] palmitate. All tracers were purchased from Cambridge
Isotopes. Additional details are described in the Supplemental Experimental
Procedures. All human pluripotent cell research was approved by the Univer-
sity of California, San Diego (UCSD) Embryonic Stem Cell Research Oversight
(ESCRO) Committee.
Immunocytochemistry
hESCs were harvested and resuspended in 1% (v/v) paraformaldehyde and
then fixed in 90% cold methanol. Cell pellets were incubated with a 1:100 dilu-
tion of human OCT-3/4 primary mouse antibody (Santa Cruz Biotechnology,
C-10) and a 1:1,000 dilution of the secondary antibody conjugated with Alexa
Fluor 488 (Molecular Probes). TheOCT4+ cells were detected by Becton Dick-
inson (BD) flow cytometry, and the results were analyzed by FlowJo. For
microscopy imaging, the adherent cells were fixed in 4% (v/v) paraformalde-
hyde. Cells were incubated with a 1:100 dilution of human OCT-3/4 primary
mouse antibody and a 1:1,000 dilution of the secondary antibody conjugated
with Alexa Fluor 488. Cells were subsequently washed and incubated with
Hoechst 33342 nucleus staining solution.
Metabolite Extraction and Derivatization
Polar metabolites and fatty acids were extracted using methanol/water/chlo-
roform. Briefly, spent medium was removed, and cells were rinsed with
0.9% (w/v) saline, and 250 ml of 80C methanol was added to quench meta-
bolism. 100 ml of ice-cold water containing 1 mg norvaline internal standardwas
added to each well. Both solution and cells were collected via scraping. Cell
lysates were transferred to fresh sample tubes, and 250 ml of 20C chloro-
form containing 1 mg heptadecanoate (internal standard for fatty acids) and
1 mg coprostan-3-ol (internal standard for cholesterol) were added. After vor-
texing and centrifugation, the top aqueous layer (polar metabolites) and bot-
tom organic layer (lipids) were collected and dried under airflow. All reagents
were purchased from Sigma-Aldrich.
Derivatization of polar metabolites was performed using the Gerstel Multi-
Purpose Sampler (MPS 2XL). Dried polar metabolites were dissolved in 20 ml
of 2% (w/v) methoxyamine hydrochloride (MP Biomedicals) in pyridine and
held at 37C for 60 min. Subsequent conversion to their tert-butyldimethylsilyl
(tBDMS) derivativeswasaccomplishedby adding 30mlN-methyl-N-(tert-butyl-
dimethylsilyl) trifluoroacetamide + 1% tert-butyldimethylchlorosilane (Regis
Technologies) and incubating at 37C for 30 min. Fatty acid methyl esters
(FAMEs) were generated by dissolving dried fatty acids in 0.5ml 2% (v/v)meth-
anolic sulfuric acid (Sigma-Aldrich) and incubating at 50C for 2hr. FAMEswere
subsequently extracted in 1 ml hexane with 0.1 ml saturated sodium chloride.
FAME samples subsequently were aliquoted to two tubes for direct analysis or
cholesterol derivatization. One dried FAME extract was converted to choles-
terol trimethylsilyl (TMS) derivatives by adding 30 mlN-Methyl-N-(trimethylsilyl)
trifluoroacetamide (Regis Technologies) and incubating at 37C for 30 min.
Gas Chromatography/Mass Spectrometry Analysis
Gas chromatography/mass spectrometry (GC/MS) analysis was performed
using an Agilent 7890A with a 30-m DB-35MS capillary column (Agilent Tech-
nologies) connected to an Agilent 5975C MS. GC/MS was operated under
electron impact (EI) ionization at 70 electronvolts (eV). In splitless mode, a
1-ml sample was injected at 270C, using helium as the carrier gas at a
flow rate of 1 ml/min. For analysis of organic and amino acid derivatives,
the GC oven temperature was held at 100C for 2 min, increased to 255C
at 3.5C/min, and then ramped to 320C at 15C/min for a total run time
of approximately 50 min. For measurement of FAMEs, the GC oven temper-
ature was held at 100C for 3 min, increased to 205C at 25C/min, further
increased to 230C at 5C/min, and ramped up to 300C at 25C/min for
a total run time of approximately 15 min. For measurement of cholesterol,
the GC oven temperature was held at 150C for 1 min, increased to
260C at 20C/min and held for 3 min, and further increased to 280C at
10C/min and held for 15 min, and finally ramped up to 325C for a total
run time of approximately 30 min. The MS source and quadrupole were
held at 230C and 150C, respectively, and the detector was operated in
scanning mode, recording ion abundance in the range of 100–650 mass-
to-charge ratio (m/z).
Metabolite Quantification and Isotopomer Spectral Analysis
For quantification of metabolites and mass isotopomer distributions, selected
ion fragments were integrated and corrected for natural isotope abundance
using an in-house, MATLAB-based algorithm and the metabolite fragments
listed in Table S1. Total abundances were normalized by counts of internal
standard control. ISA for quantitation of [1,2-13C2] glucose and [U-
13C6]
glucose contribution to lipogenic AcCoA and [3-2H] glucose contribution to
lipogenic NADPH were calculated as described previously (Vacanti et al.,
2014; Lewis et al., 2014). Specifically, the relative enrichment of the lipogenic
AcCoA andNADPHpools from a given tracer and the percentage of newly syn-
thesized fatty acids were estimated from a best fit model using the isotopomer
network compartmental analysis (INCA)MFA software package (Young, 2014).
The 95% confidence intervals (CIs) for both parameters were determined byevaluating the sensitivity of the sum of squared residuals between measured
and simulated palmitate mass isotopomer distributions to small flux variations
(Antoniewicz et al., 2006).
Mole Percent Enrichment Measurement
Mole percent enrichment (MPE) of isotopeswas calculated as the percent of all
atoms within the metabolite pool that are labeled
Pn
i = 1Mi,i
n
;
where n is the number of carbon atoms in the metabolite andMi is the relative
abundance of the ith mass isotopomer.
Extracellular Flux and Oxidative Pentose Phosphate Pathway Flux
Measurements
Per-dry cell weight extracellular fluxes, including glucose/glutamine uptake
and Lac/glutamate secretion, were calculated by subtracting final spent me-
dium from initial medium substrate concentrations measured using a Yellow
Springs Instrument 2950 and normalized by the integral dry weights of hPSCs
over 24 hr (Vacanti et al., 2014). Quantification of oxidative PPP flux was deter-
mined by extracellular glucose uptake flux times the ratio of
M+ 1
ðM+ 1Þ+ ðM+ 2Þ;
where (M + 1) and (M + 2) are the isotopologues of Pyr derived from [1,2-13C2]
glucose.
Cell Dry Weight Measurements
hPSCswere harvested and counted at 90%confluence. Cell pellets were dried
by ambient air at 50C for 3 days. Total weights of cell pellets were then
measured, and weight per million cells was calculated.
ATP-Linked Oxygen Consumption Rate Measurements
Respiration was measured in viable hPSCs using a Seahorse XF96 analyzer.
hPSCswere assayed in fresh culturemedia. The ATP-linked oxygen consump-
tion rate (OCR) was calculated as the oxygen consumption rate sensitive to
2mg/ml oligomycin under each culture condition and normalized by cell abun-
dance. Each culture condition sample had at least four biological replicates
analyzed. Cell abundance was indicated by the total fluorescence after stain-
ing with Hoechst 33342 (Divakaruni et al., 2014).
Gene Expression Analysis
Total mRNA was isolated from 75% confluent hPSCs using an RNA isola-
tion kit (RNeasy mini kit, QIAGEN). Isolated RNA was reverse-transcribed
using a cDNA synthesis kit (iScipt Reverse Transcription Supermix, Bio-
Rad). Real-time PCR was performed using SYBR Green reagent (iTaq Uni-
versal SYBR Green Supermix, Bio-Rad). Relative expression was deter-
mined using the Livak (DDCT) method with GAPDH as the housekeeping
gene. The primers used were taken from Primerbank (Wang et al., 2012)
and tabulated in Table S2. All commercial kits were used according to
the manufacturer’s protocol.
Statistical Analyses
All results shown are as averages of triplicates (at least) and presented as
mean ± SEM. p values were calculated using Student’s two-tailed t test
(*p = between 0.01 and 0.05, **p = between 0.001 and 0.01, ***p < 0.001). All
errors associated with ISA were 95% confidence intervals determined via con-
fidence interval analysis.
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